Tourbillon Capital Partners LP Shows New 6.2% Stake in Sarepta Therapeutics (SRPT)

October 28, 2016 9:22 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

In a 13G filing on Sarepta Therapeutics (Nasdaq: SRPT) today, hedge fund Tourbillon Capital Partners LP disclosed a 6.2%, or 3,332,300 share, stake in the company. The firm did not hold shares at the end of the latest quarter ending September 30, 2016.

For more notable holders of Sarepta Therapeutics stock click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

13Gs, Hedge Funds

Related Entities

13G

Add Your Comment